Emerging Role and Function of Th9 Cells in Allergic Inflammation

Area of Science:

• Immunology
• Allergic Inflammation
• Cellular Mechanisms

Background:

• Th9 cells are key drivers of allergic inflammation in airway, skin, and nasal mucosa.
• They represent a distinct immune axis separate from canonical Th2 immunity.
• This review focuses on Th9 cells' role in asthma, atopic dermatitis, and allergic rhinitis.

Purpose of the Study:

• To highlight the Th9 axis as a unifying factor in allergic diseases.
• To detail the mechanistic programs governing Th9 cell function.
• To explore organ-level phenotypes and therapeutic implications of Th9 cells.

Main Methods:

• Review of existing literature on Th9 cell differentiation, function, and regulation.
• Analysis of signaling pathways including STAT5/STAT6, PPARγ-mTORC1, and IL-9-MCT1.
• Examination of clinical and experimental data on Th9-mediated phenotypes like BHR.

Main Results:

• Th9 cells differentiate under IL-4 and TGF-β, secreting IL-9 to promote inflammation and remodeling.
• Epigenetic licensing by STAT5/STAT6 and metabolic wiring via PPARγ-mTORC1 sustain Th9 effector function.
• Th9-driven BHR is eosinophil-independent and shows relative glucocorticoid resistance.
• Th9 signatures explain non-Th2 asthma endotypes unresponsive to standard therapies.

Conclusions:

• Th9 cells are a unifying driver of asthma, atopic dermatitis, and allergic rhinitis.
• Targeting Th9 cell pathways, including JAK inhibition and TL1A/DR3 blockade, offers therapeutic potential.
• Biomarker-guided endotyping and upstream pathway intervention are promising strategies for Th9-dependent diseases.